Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations
- PMID: 12866375
- DOI: 10.1309/ND8D-9LAJ-TRCT-G6QD
Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations
Abstract
The follicular variant (FV) of papillary thyroid carcinoma is characterized by a follicular growth pattern and cytologic features of papillary carcinoma. ret/PTC rearrangements are common in classic papillary thyroid carcinoma (PTC) and PAX8-PPAR gamma and ras mutations in follicular thyroid carcinoma. Their prevalence in FV has not been established. We studied these genetic alterations and clinical-pathologic features in 30 FV cases and compared those with 46 non-FV papillary carcinomas. FV cases revealed 1 ret/PTC rearrangement (3%) and 13 ras mutations (43%). Non-FV cases harbored 13 ret/PTC (28%) (P = .006) and no ras mutations (P = .0002). No PAX8-PPAR gamma was found in either group. FV cases demonstrated a significantly higher prevalence of tumor encapsulation, angiovascular invasion, and poorly differentiated areas and a lower rate of lymph node metastases. These data indicate that the FV of papillary carcinoma has a distinct set of molecular alterations and is characterized by a high frequency of ras point mutations.
Comment in
-
ras mutations in follicular variant of papillary thyroid carcinoma.Am J Clin Pathol. 2003 Nov;120(5):803; author reply 804. Am J Clin Pathol. 2003. PMID: 14608909 No abstract available.
Similar articles
-
RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma.J Clin Endocrinol Metab. 2003 May;88(5):2318-26. doi: 10.1210/jc.2002-021907. J Clin Endocrinol Metab. 2003. PMID: 12727991
-
PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma.J Clin Endocrinol Metab. 2006 Jan;91(1):213-20. doi: 10.1210/jc.2005-1336. Epub 2005 Oct 11. J Clin Endocrinol Metab. 2006. PMID: 16219715
-
Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas.J Clin Endocrinol Metab. 2002 Aug;87(8):3947-52. doi: 10.1210/jcem.87.8.8756. J Clin Endocrinol Metab. 2002. PMID: 12161538
-
[Oncogenes and thyroid tumors].Bull Cancer. 2005 Jan;92(1):37-43. Bull Cancer. 2005. PMID: 15689324 Review. French.
-
Molecular pathology of well-differentiated thyroid carcinomas.Virchows Arch. 2005 Nov;447(5):787-93. doi: 10.1007/s00428-005-0065-5. Epub 2005 Sep 28. Virchows Arch. 2005. PMID: 16189702 Review.
Cited by
-
Understanding the genotype of follicular thyroid tumors.Endocr Pathol. 2005 Winter;16(4):311-21. doi: 10.1385/ep:16:4:311. Endocr Pathol. 2005. PMID: 16627918 Review.
-
Clinical-Pathological and Molecular Evaluation of 451 NIFTP Patients from a Single Referral Center.Cancers (Basel). 2022 Jan 14;14(2):420. doi: 10.3390/cancers14020420. Cancers (Basel). 2022. PMID: 35053581 Free PMC article.
-
Variations in MAP kinase gladiators and risk of differentiated thyroid carcinoma.Mol Clin Oncol. 2022 Feb;16(2):45. doi: 10.3892/mco.2021.2478. Epub 2021 Dec 23. Mol Clin Oncol. 2022. PMID: 35003743 Free PMC article.
-
Absence of allelic imbalance involving EMSY, CAPN5, and PAK1 genes in papillary thyroid carcinoma.J Endocrinol Invest. 2008 Jul;31(7):618-23. doi: 10.1007/BF03345613. J Endocrinol Invest. 2008. PMID: 18787380
-
Controversies in thyroid pathology: the diagnosis of follicular neoplasms.Endocr Pathol. 2008 Fall;19(3):156-65. doi: 10.1007/s12022-008-9031-5. Endocr Pathol. 2008. PMID: 18548351 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical